Six clinical trials tracked from first filing to outcome. Each case reconstructs how the model's probability shifted in response to registry events — and whether the final call matched reality. Covers Roche, Regeneron, Abivax, Akeso, Sanofi, and Praxis.
Source-linked intelligence across regulated markets, scoped to your domain.